Our Objective

The mission of the Pharmacogenomics Global Research Network (PGRN) is to catalyze and lead research in precision medicine for the discovery and translation of genomic variation influencing therapeutic and adverse drug effects.

Message from Founder and
Inaugural President (2020-21)
Kathy Giacomini, PhD


Message from Founder and
President (2021-22)
Andrew Monte, MD, PhD


Message from Founder and
Inaugural Treasurer (2020-22)
Ronald Krauss, MD


Message from Founder

Kelly E. Caudle, PharmD, PhD
CPIC Co-PI and Director


Who We Were

PGRN IV was established July 1, 2015, and represented a continuation of research activities, however in a new model. The model invited participation of all investigators with an interest in pharmacogenomics research to be part of a network.

Then a new PGRN was formed to consist of three large center grant projects, two enabling resources for pharmacogenomics, a knowledgebase, PharmGKB, and a PGRN Hub, established to coordinate activities of the PGRN in order to catalyze research in pharmacogenomics and precision medicine.

Origins of Pharmacogenetics

Our History

Click here for the PGRN History.pdf

The Pharmacogenomics Research Network, PGRN I–III was funded from 2000 through 2015 by multiple Institutes and Centers of the NIH. The network catalyzed pharmacogenomics discoveries both nationally and internationally through the conduct of collaborative research focused on the discovery and translation of the genetic determinants of drug response, in order to enable safer and more effective drug therapies. 

Copyright © 2020 the Pharmacogenomics Global Research Network. All Rights Reserved.

PGRN is a 501(c)3 Non-Profit Association

Follow PGRN
on Social Media

Become a Member

PGRN logo
Membership dues are vital to continue the mission and work of the PGRN. Join your colleagues today and suport the work of PGRN. 
Powered by Wild Apricot Membership Software